BlackRock’s CARGO Therapeutics CRGX Stock Holding History

BlackRock’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,707,182	Closed	-$11.2M	–	5476
2025 Q2	$11.2M	Sell	2,707,182 -72,448	-3%	-$310K	﹤0.01%	3359
2025 Q1	$11.3M	Sell	2,779,630 -95,360	-3%	-$639K	﹤0.01%	3255
2024 Q4	$41.5M	Buy	2,874,990 +327,909	+13%	+$5.95M	﹤0.01%	2571
2024 Q3	$47M	Buy	2,547,081 +1,087,437	+75%	+$19.5M	﹤0.01%	2504
2024 Q2	$24M	Sell	1,459,644 -11,863	-0.8%	-$226K	﹤0.01%	2865
2024 Q1	$32.8M	Buy	1,471,507 +1,211,864	+467%	+$28.8M	﹤0.01%	2694
2023 Q4	$6.01M	Buy	+259,643	New	+$4.4M	﹤0.01%	3618

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BlackRock's CRGX Position: Q3 2025 in Review

BlackRock sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 2,707,182 shares — an estimated $11.2M sold.

BlackRock first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $47M in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

BlackRock reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
BlackRock sold 2,707,182 CARGO Therapeutics shares in Q3 2025, an estimated $11.2M.
BlackRock first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
BlackRock's CARGO Therapeutics position peaked at $47M in Q3 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on BlackRock's 13F filing for Q3 2025, filed 12 Nov 2025.